Crohn's Disease-associated variant in laccase domain containing 1 (LACC1) modulates T ... - Nature nature.com

Crohn's Disease-associated variant in laccase domain containing 1 (LACC1) modulates T ... - Nature

2 min read
Research and clinical trials Genetics and genomics Basic Science Researchers Clinicians Adult patients Newly Diagnosed Crohn's disease
Why This Matters

The paper links a Crohn’s disease GWAS signal to reduced LACC1 expression in lymphocytes and to altered immunometabolic function, clarifying a potential mechanism by which genetic variation contributes to IBD risk. It advances basic understanding of disease biology but does not report new treatments.

Who Should Pay Attention

Researchers (IBD genetics, immunology, metabolism), clinicians interested in IBD pathogenesis, and informed patients following IBD research

What To Know

What to know This Nature article reports laboratory and human-genetics work linking common and rare LACC1 (C13ORF31/FAMIN) variants to altered LACC1 expression and immune/metabolic functions in lymphocytes and myeloid cells, with relevance to Crohn’s disease and other inflammatory bowel diseases.

The authors use population genetics (eQTL analyses), cellular assays, and experimental models to trace how a CD-associated noncoding variant reduces LACC1 expression in T cells and how coding variants can change protein function. They then examine downstream effects on cellular metabolism and immune responses that could plausibly influence colitis risk.

Why this matters This study helps pinpoint LACC1 as a likely causal gene at an IBD GWAS locus and shows the cell types (notably T cells and myeloid cells) and pathways (immunometabolism) that may mediate genetic risk. Results are primarily mechanistic and advance understanding of disease biology rather than changing clinical care today.

Who should pay attention Researchers studying IBD genetics, immunometabolism, and disease mechanisms; clinicians interested in the genetic underpinnings of Crohn’s disease and IBD; and patients who follow IBD research and genetic risk discoveries.

Keep In Mind

This is a mechanistic, laboratory-based study using human genetics and cellular/animal experiments. Findings clarify biology at a GWAS locus but are early-stage; they do not imply immediate clinical changes. Read the full paper for methods and limitations.

This Cure8 note is AI-assisted and based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Read Original Article Originally published Mar 16, 2025, 12:38 AM
Advertisement Space

Related Articles